Latest News for: 749
Edit
Griffith Announces $983,749 in HHS Grants to Virginia Tech (Morgan Griffith)
Public Technologies 01 May 2026
). The U.S. Department of Health and Human Services (HHS) has awarded Virginia Tech, based in Blacksburg, Virginia, two grants that total $983,749. The breakdown for the grants includes ... BACKGROUND ... ###. Attachments Original document Permalink. Disclaimer.
Edit
Vietnam Quick Commerce Databook Report 2026: Market to Reach $749.5 Billion by 2029 - 100+ ...
Nasdaq Globe Newswire 17 Apr 2026
Expanding delivery efficiencies and enhancing consumer behavior analysis are pivotal ... .
Edit
Kerala Karunya KR-749 lottery result declared today, 11-04-2026; Check who won ₹1 crore and complete winners list here
The Times of India 11 Apr 2026
Edit
Kerala Lottery Result Today Live: Karunya KR-749 Ticket KO 665447 Wins Rs 1 Crore (11/04/2026) ...
News18 11 Apr 2026
Edit
TESCO Metering Introduces Model 749 Utility Meter Storage Rack for Electric Utility Meter Shops
PR Newswire 09 Mar 2026
Edit
The Capital Journal
03 Mar 2026
Walmart's bestselling $999 gaming PC is on sale for $749, and it has a high-performance processor
Edit
Save Ohio Parks: Public comments needed to stop fracking 8,749 acres at Salt Fork, Egypt Valley
PR Newswire 24 Feb 2026
Comments needed by March 7 for 6,639 acres in Egypt Valley Wildlife Area; March 15 for 513 acres under Salt Fork State Park and 1,596 more acres of Egypt Valley. COLUMBUS, Ohio, Feb ... The wildlife area is popular for hiking, fishing, and hunting ... 21% ... .
Edit
Medincell: U.S. Food and Drug Administration (FDA) Accepts Teva’s New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults
Pharmiweb 20 Feb 2026
Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for olanzapine extended-release injectable suspension (TEV-'749) for the treatment of schizophrenia in adults. TEV-'749 is ...
Edit
Medincell: U.S. Food and Drug Administration (FDA) Accepts Teva’s New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults (Medincell SA)
Public Technologies 20 Feb 2026
Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for olanzapine extended-release injectable suspension (TEV-'749) for the treatment of schizophrenia in adults. TEV-'749 is ...
- 1
- 2
- Next page »